<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Merck of Germany (Industry News &amp; Blogs)</title><link>http://www.zibb.com/all/theme/cq/Merck+of+Germany</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Merck+of+Germany" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Thu, 02 Oct 2008 20:05:26 GMT</pubDate><lastBuildDate>Thu, 02 Oct 2008 20:05:26 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Merck of Germany (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Merck+of+Germany</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>BMS faces pressure on ImClone bid (at FT.com)</title><link>http://us.ft.com/ftgateway/superpage.ft?news_id=fto100220081612273946&amp;referrer_id=yahoofinance</link><description>Pressure was mounting on Bristol-Myers Squibb on Thursday to raise its $62 a share unsolicited offer for ImClone, the US biotech company, which said it was continuing negotiations with a second "mystery bidder".</description><guid>http://us.ft.com/ftgateway/superpage.ft?news_id=fto100220081612273946&amp;referrer_id=yahoofinance</guid><category domain="http://www.zibb.com">Merck of Germany</category><pubDate>Thu, 02 Oct 2008 20:05:26 GMT</pubDate><source url="http://us.ft.com" /></item><item><title>German Merck Profit Soars on Serono Deal</title><link>http://www.newsvine.com/_news/2008/02/18/1308961-german-merck-profit-soars-on-serono-deal</link><description>Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly $5 billion as it reaped the benefits of its acquisition of Serono and the divestiture of its generic</description><guid>http://www.newsvine.com/_news/2008/02/18/1308961-german-merck-profit-soars-on-serono-deal</guid><category domain="http://www.zibb.com">Merck of Germany</category><pubDate>Mon, 18 Feb 2008 15:24:42 GMT</pubDate><source url="http://www.newsvine.com" /></item><item><title>Germany's Merck 4Q profit soars on Serono deal, divestment of gen...
      </title><link>http://www.iht.com/articles/ap/2008/02/18/business/EU-FIN-EARNS-Germany-Merck.php</link><description>Germany's Merck 4Q profit soars to nearly €3.4B on Serono deal, divestment of generics unit</description><guid>http://www.iht.com/articles/ap/2008/02/18/business/EU-FIN-EARNS-Germany-Merck.php</guid><category domain="http://www.zibb.com">Merck of Germany</category><pubDate>Mon, 18 Feb 2008 10:08:31 GMT</pubDate><source url="http://www.iht.com" /></item></channel></rss>